One of the greatest challenges in cancer treatment is maximising the response to a given drug - how can doctors get the greatest impact for the patient from the drug?
Traditionally, the answer to this has been ‘maximum tolerated dose’ (MTD) therapy, where the patient continually receives a high drug dose, with no breaks in treatment.